Be Biopharma to Present at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting April 24, 2024
Pulmocide Announces Successful Results from the OPERA-S Study: a Phase 2 Safety Study with Inhaled Opelconazole April 23, 2024
AAVantgarde Presents Positive Preclinical Data in Large Animal Models from its Stargardt Disease Program in an Oral Presentation at the ASGCT 2024 Annual Meeting April 23, 2024
TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities April 17, 2024
Immunitas Therapeutics Presents Preclinical Data Supporting Combination of IMT-009 with Anti-PD1 Immunotherapy at the AACR April 9, 2024
